Denmark's framework conditions for generics and biosimilars are exceptionally strong. As a society we should be grateful for that and protect it.
In Conversation
Our goal is not to disrupt convention for its own sake, but to introduce a novel therapeutic paradigm underpinned by a clear scientific rationale and advanced…
Our vision is clear...In ophthalmology, you cannot rely on just one or two products. You must serve the entire field.
What sets us apart is simple: our products are clinically substantiated. We walk into a room with data, not just marketing.
This journey has reminded me that leadership is not defined by institutional scale, but by resilience, clarity of purpose, and the ability to deliver.
As long as we stay anchored in innovation and aligned with patient needs, we are confident in our ability to grow, differentiate, and endure.
We envision a future where data-driven collaboration in Alzheimer’s research leads to faster breakthroughs, supported by AI and quantum computing technologies.
For physicians and patients, these approvals are vital: after roughly two decades without a single approved Alzheimer’s treatment, having options restores hope and underscores the importance…
While I may serve as the face of Rivopharm, the credit belongs to the team, their consistency and belief in our shared goals define who we…
The real innovation lies not in delivery, but in identifying the right biological target and acting on it with precision.
That experience showed me what was possible when you align people and processes with purpose.
At ALK, we see enormous potential to reach more people with solutions that genuinely change lives. The Allergy+ framework helps articulate not only where we are…
